NasdaqCM:TGTXBiotechs
Assessing TG Therapeutics (TGTX) Valuation After New BRIUMVI Data And Christina Applegate MS Campaign
TG Therapeutics (TGTX) has been in focus after presenting new BRIUMVI data for relapsing multiple sclerosis at the ACTRIMS forum and launching a national MS awareness campaign with actress Christina Applegate.
See our latest analysis for TG Therapeutics.
At a share price of US$29.58, TG Therapeutics has seen recent momentum pick up, with a 1 month share price return of 3.9% following BRIUMVI data updates and the Christina Applegate MS awareness campaign. This compares with a 1 year total...